McAdams Wright Ragen’s Bristol-Myers Squibb BMY Stock Holding History

McAdams Wright Ragen’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	$3.76M	Sell	73,497 -6,479	-8%	-$324K	0.21%	105
2014 Q2	$3.88M	Buy	79,976 +5,161	+7%	+$254K	0.22%	95
2014 Q1	$3.89M	Sell	74,815 -2,677	-3%	-$142K	0.24%	89
2013 Q4	$4.12M	Sell	77,492 -9,458	-11%	-$482K	0.27%	91
2013 Q3	$4.02M	Buy	86,950 +10,261	+13%	+$450K	0.32%	80
2013 Q2	$3.43M	Buy	+76,689	New	+$3.33M	0.27%	95

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

McAdams Wright Ragen's BMY Position: Q3 2014 in Review

McAdams Wright Ragen reduced its Bristol-Myers Squibb (BMY) stake by 8.1% in Q3 2014, selling an estimated $324K and leaving 73,497 shares worth $3.76M. The position accounts for 0.21% of the portfolio, ranked #105.

McAdams Wright Ragen first reported a position in BMY in Q2 2013 and has held it in 6 quarters since. The position peaked at $4.12M in Q4 2013. 1,301 funds tracked by Wall St. Rank hold BMY as of Q3 2014.

McAdams Wright Ragen held 73,497 shares of Bristol-Myers Squibb worth $3.76M as of Q3 2014.
McAdams Wright Ragen sold 6,479 Bristol-Myers Squibb shares in Q3 2014, an estimated $324K.
Bristol-Myers Squibb made up 0.21% of McAdams Wright Ragen's portfolio in Q3 2014, its #105 holding.
McAdams Wright Ragen first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 6 quarters since.
McAdams Wright Ragen's Bristol-Myers Squibb position peaked at $4.12M in Q4 2013.
1,301 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2014.

Based on McAdams Wright Ragen's 13F filing for Q3 2014, filed 14 Nov 2014.